Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide

This publication has 34 references indexed in Scilit:

• Induction of sister chromatid exchanges by the peroxisome proliferators 2, 4-D, MCPA, and clofibrate in vivo and in vitro
  Carcinogenesis: Integrative Cancer Research, 1984
• Neoplastic conversion in rat liver by the antihistamine methapyrilene demonstrated by a sequential syncarcinogenic effect with N-2-fluorenylacetamide
  Toxicology and Applied Pharmacology, 1984
• Induction by butylated hydroxytoluene of rat liver γ-glutamyl transpeptidase activity in comparison to expression in carcinogen-induced altered lesions
  Chemico-Biological Interactions, 1984
• An enhancing effect of the antihistaminic drug methapyrilene on rat liver carcinogenesis by previously administered N-2-fluorenylacetamide
  Toxicology and Applied Pharmacology, 1983
• Incorporation of radioactivity from labeled di-(2-ethylhexyl)phthalate into DNA of rat liver in vivo
  Chemico-Biological Interactions, 1983
• Effects of various concentrations of ethyl-α-p-chlorophenoxyisobutyrate (clofibrate) on diethylnitrosamine-induced hepatic tumorigenesis in the rat
  Carcinogenesis: Integrative Cancer Research, 1982
• Detection of peroxisomal fatty acyl-coenzyme A oxidase activity
  Biochemical Journal, 1979
• Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
  The Journal of cell biology, 1975
• Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate
  Toxicology and Applied Pharmacology, 1972
• Lipid effects of a phenolic ether (Su-13437) in the rat: Comparison with CPIB
  Atherosclerosis, 1970